Physician profile
Celso E Dias
NPI 1396994109
$22,845.41
in general payments reported to CMS, 2019-2025
11 companies · $7,463 in 2025
The $7,463 reported for 2025 was more than what 88% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $652 · 2020: $1,373 · 2021: $1,074 · 2022: $967 · 2023: $4,852 · 2024: $6,465 · 2025: $7,463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $14K · Food and Beverage: $4,438 · Consulting Fee: $450.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $13,893.33 |
| Food and Beverage | $4,437.59 |
| Consulting Fee | $450.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $14,253.83 | 2020-2025 | Venacure 1470 Pro, Venacure 1470 Pro |
| Medtronic, INC. | $3,305.34 | 2021-2025 | Abre, Endurant Iis, In.Pact Admiral |
| Cardiovascular Systems INC. | $1,019.67 | 2019-2023 | Diamondback Peripheral |
| W. L. Gore & Associates, INC. | $894.60 | 2019-2024 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Viabahn Vbx Balloon Expandable Endo |
| Boston Scientific Corporation | $793.30 | 2020-2025 | Eluvia, Angiojet Ultra 5000a, Athletis |
| Terumo Medical Corporation | $732.87 | 2020-2025 | R2p Misago, Glidesheath Slender, Angio-Seal |
| Abbott Laboratories | $725.04 | 2019-2025 | Jeti All In One Non-Sterile Kit, Jeti Peripheral Catheter, Diamondback Peripheral |
| Philips North America LLC | $459.98 | 2021-2025 | IV Other |
| Cook Medical LLC | $322.53 | 2019-2020 | |
| Medtronic Vascular, INC. | $268.64 | 2019-2020 | |
| Solventum Corporation | $69.61 | 2025 | Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Celso Dias listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.